Clinical evaluation of random biopsy of urinary bladder in patients with superficial bladder cancer

International Journal of Urology

Volumn 5, Issue 1, 1998, Pages 30-34

  Taguchi, Isao ^a   Gohji, Kazuo ^a   Hara, Isao ^a   Gotoh, Akinobu ^a   Yamada, Yuji ^a   Yamanaka, Kazuki ^a   Okada, Hiroshi ^a   Arakawa, Soichi ^a   Kamidono, Sadao ^a  

^a KOBE UNIVERSITY   (Japan)

Author keywords

CIS; Dysplasia; Random biopsy; Superficial bladder cancer

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER BIOPSY; BLADDER CANCER; BLADDER PAPILLOMA; CANCER DIAGNOSIS; CANCER SURVIVAL; CARCINOMA IN SITU; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0031929707     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-2042.1998.tb00229.x     Document Type: Article

References (20)

1. Heney NM, Ahmed S, Flanagan MJ, Frable W, Corder MP, Hafermann MD, Hawkins IR, National Bladder Cancer Cooperative Group A. Superficial bladder cancer: progression and recurrence. J Urol 1983;130:1083-1086.
2. Flamm J, Dona S. The significance of bladder quadrant biopsies in patients with primary superficial bladder carcinoma. Eur Urol 1989;16:81-85.
3. Smith G, Elton RA, Beynon LL, Newsam JE, Chisholm GD, Hargreave TB. Prognostic significance of biopsy results of normal-looking mucosa in cases of superficial bladder cancer. Brit J Urol 1983;55:665-669.
4. Althausen AF, Prout GR Jr, Daly JJ. Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ. J Urol 1976;116:575-580.
5. Kiemeney LALM, Witjes JA, Heijbroek RP, Verbeek ALM, Debruyne FMJ. Predictability of recurrent and progressive disease in individual bladder cancer. J Urol 1993;150:60-64.
6. Kiemeney LALM, Witjes JA, Heijbroek RP, Debruyne FMJ, Verbeek ALM. Dysplasia in normal-looking urothelium increases the risk of tumour progression in primary superficial bladder cancer. Eur J Cancer 1994; 30A:1621-1625.
7. Soloway MS, Murphy W, Rao MK, Cox C. Serial multi-ple-site biopsies in patients with bladder cancer. J Urol 1978;120:57-59.
8. Heney NM, Daly J, Prout GR Jr, Nieh PT, Heaney JA, Trebeck NE. Biopsy of apparently normal urothelium in patients with bladder carcinoma. J Urol 1978;120:559-560.
9. Prout GR Jr, Griffin PP, Daly JJ, Heney NM. Carcinoma in situ of the urinary bladder with and without associated vesical neoplasms. Cancer 1983;52:524-532.
10. Soloway MS, Masters S. Urothelial susceptibility to tumor cell implantation. Influence of cauterization. Cancer 1980; 46:1158-1163.
11. Mostofi SK, Sobin LH, Torloni H. Histological typing of urinary bladder tumours. International histological classification of tumours. 10. Geneva: World Health Organization, 1973.
12. Beathrs OH, Henson DE, Hutter RVP, Kennedy BJ. Manual for staging of cancer. 4th ed. Philadelphia: JB Lippincott, 1992.
13. Eto H, Oka Y, Ueno K, Nakamura I, Yoshimura K, Arakawa S, Kamidono S, Obe S, Ogawa T, Hamami G, Yamanaka N, and Kobe University Urological Oncology Group. Comparison of the prophylactic usefulness of epirubicin and doxorubicin in the treatment of superficial bladder cancer by intravesical instillation: a multicenter randomized trial. Cancer Chemother Pharmacol 1994;35(suppl): S46-S51.
14. Gohji K, Hara I, Taguchi I, Ueno K, Yamada Y, Eto H, Arakawa S, Kamidono S, Obe S, Ogawa T, Hamami G, Yamanaka N, and Kobe University Urological Oncology Group. Long-term results of a randomized study of intravesical instillation of epirubicin and doxorubicin as a prophylaxis against superficial bladder cancer recurrence. Nishinippon J Urol 1997;59:785-791.
15. Eisenberg RB, Roth RB, Schweinsberg MH. Bladder tumors and associated proliferative mucosal lesions. J Urol 1960;84:544-550.
16. Droller MJ. The natural history of invasive bladder cancer and the case against definitive radiation therapy. World J Urol 1985;3:86-93.
17. Kiemeney LALM, Witjes JA, Heijbroek RP, Koper NP, Verbeek ALM, Debruyne FMJ. Should random urothelial biopsies be taken from patients with primary superficial bladder cancer? A decision analysis. Brit J Urol 1994;73: 164-171.
18. Morales A, Edinger D, Bruce AW. Intracavitary bacillus Calmette-Guérin in the treatment of superficial bladder tumors. J Urol 1976; 116:180-183.
19. Brosman SA. The use of bacillus Calmette-Guérin in the therapy of bladder carcinoma in situ. J Urol 1985;134: 36-39.
20. Akaza H, Hinotsu S, Aso Y, Kakizoe T, Koiso K. Bacillus Calmette-Guérin treatment of existing papillary bladder cancer and carcinoma in situ of the bladder. Cancer 1995;75:552-559.